AIRLINK 80.60 Increased By ▲ 1.19 (1.5%)
BOP 5.26 Decreased By ▼ -0.07 (-1.31%)
CNERGY 4.52 Increased By ▲ 0.14 (3.2%)
DFML 34.50 Increased By ▲ 1.31 (3.95%)
DGKC 78.90 Increased By ▲ 2.03 (2.64%)
FCCL 20.85 Increased By ▲ 0.32 (1.56%)
FFBL 33.78 Increased By ▲ 2.38 (7.58%)
FFL 9.70 Decreased By ▼ -0.15 (-1.52%)
GGL 10.11 Decreased By ▼ -0.14 (-1.37%)
HBL 117.85 Decreased By ▼ -0.08 (-0.07%)
HUBC 137.80 Increased By ▲ 3.70 (2.76%)
HUMNL 7.05 Increased By ▲ 0.05 (0.71%)
KEL 4.59 Decreased By ▼ -0.08 (-1.71%)
KOSM 4.56 Decreased By ▼ -0.18 (-3.8%)
MLCF 37.80 Increased By ▲ 0.36 (0.96%)
OGDC 137.20 Increased By ▲ 0.50 (0.37%)
PAEL 22.80 Decreased By ▼ -0.35 (-1.51%)
PIAA 26.57 Increased By ▲ 0.02 (0.08%)
PIBTL 6.76 Decreased By ▼ -0.24 (-3.43%)
PPL 114.30 Increased By ▲ 0.55 (0.48%)
PRL 27.33 Decreased By ▼ -0.19 (-0.69%)
PTC 14.59 Decreased By ▼ -0.16 (-1.08%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.75 Decreased By ▼ -0.75 (-1.11%)
SSGC 11.00 Decreased By ▼ -0.09 (-0.81%)
TELE 9.11 Decreased By ▼ -0.12 (-1.3%)
TPLP 11.46 Decreased By ▼ -0.10 (-0.87%)
TRG 70.23 Decreased By ▼ -1.87 (-2.59%)
UNITY 25.20 Increased By ▲ 0.38 (1.53%)
WTL 1.33 Decreased By ▼ -0.07 (-5%)
BR100 7,629 Increased By 103 (1.37%)
BR30 24,842 Increased By 192.5 (0.78%)
KSE100 72,743 Increased By 771.4 (1.07%)
KSE30 24,034 Increased By 284.8 (1.2%)

imageAndrew Calabrese, a third grader was just three years old when his pancreas gave up, rendering him with the dreaded Type-1 diabetes for life.

However, his parents Heidi and Jason didn’t gave up hope, and Jason, a software engineer by profession, developed a device that could help regulate his son’s insulin levels i.e. a robotic pancreas.

According to Wall Street Journal, Jason was able to make an artificial pancreas for his son, using the OpenAPS (Open Artificial Pancreas System), which is a free online project in order to make the APS technology widely available, so that lives could be saved and the burden of Type 1 diabetes can be reduced.

As per Oddity Central, the APS was developed by a 27 year old Dana Lewis in December 2014, a Type 1 diabetic himself. The OpenAPS provides “a safety-focused reference design, a toolset, and an open source reference implementation that can be used by any individual – or any medical device manufacturer.”

imageFollowing the instructions, Jason learnt how to use an old insulin pump to control blood glucose (BG) levels, automatically, both overnight and in between meals. The software engineer added a Continuous Glucose Monitor (CGM) to provide BG data to the pump, and command it to adjust the temporary basal rates accordingly.

Andrew finally began using OpenAPS to keep in check his insulin levels, after doctor’s approval. “OpenAPS is there when I can’t be,” Jason said. “It’s cut the time Andrew spends below 80 mg/dL in half.”

“Diabetes is dangerous anyway. Insulin is dangerous. I think what we are doing is actually improving that and lowering the risk,” he added. However, Jason admitted that this solution is still subjected to pump or tubing failures, and that the insulin dosing for meals is still needed to be done manually.

Copyright Business Recorder, 2016

Comments

Comments are closed.